Abstract
Objective To observe the efficacy and safety of oral moxifloxacin in the treatment of outpatients with community-acquired pneumonia. Methods Fifty-six cases of community-acquired pneumonia patients used oral moxifloxacin. Meanwhile, the other 60 cases of patients used intravenous levofloxacin. Clinic index,bacterium clearance,curative effect and safety were observed. Results The clinical efficacy in the trial and control group were 94.6% and 92.6% respectively,and the bacterial eradication rates were 90.0% and 90.2%, The adverse drug reaction rates were evaluated in all patients, showing the rates were 7.1% and 18.5%. Conclusions Oral moxifloxacin is effective,simple and safe in the treatment of outpatients with community-acquired pneumonia. Key words: Community-acquired pneumonia; Moxifloxacin; Levofloxacin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
